Hongying Su
- Co-authors
- Han BaoXiongfei HuangAimin HuangWendong HuangJingfeng LiuXichun WangNingbo LiJingsong Mao
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (6 papers)RNA Research and Splicing (4 papers)Cancer Mechanisms and Therapy (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Hongying Su
20 papers receiving 355 citations
Peers
Comparison fields: 5 of 69
- Molecular Biology 120
- Oncology 96
- Hepatology 92
- Surgery 82
- Epidemiology 67
Countries citing papers authored by Hongying Su
This map shows the geographic impact of Hongying Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongying Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongying Su more than expected).
Fields of papers citing papers by Hongying Su
This network shows the impact of papers produced by Hongying Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongying Su. The network helps show where Hongying Su may publish in the future.
Co-authorship network of co-authors of Hongying Su
This figure shows the co-authorship network connecting the top 25 collaborators of Hongying Su. A scholar is included among the top collaborators of Hongying Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongying Su. Hongying Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 7 | |
| 3 | 18 | |
| 4 | 3 | |
| 5 | 11 | |
| 6 | 4 | |
| 7 | 34 | |
| 8 | 8 | |
| 9 | 31 | |
| 10 | 19 | |
| 11 | 9 | |
| 12 | 23 | |
| 13 | The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib. | 1 |
| 14 | 12 | |
| 15 | 0 | |
| 16 | 89 | |
| 17 | 11 | |
| 18 | [Analysis of severe complications after transcatheter arterial chemoembolization for primary hepatocellular carcinoma]. | 4 |
| 19 | Clinical application of interventional techniques in the treatment of Budd-Chiari syndrome. | 39 |
| 20 | Clinical application study on thrombectomy of iliac-femoral venous thrombosis via transjugular approach | 1 |
About Hongying Su
Hongying Su is a scholar working on Hepatology, Internal Medicine and Cancer Research, having authored 21 papers that have together received 358 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), RNA Research and Splicing (4 papers) and Cancer Mechanisms and Therapy (3 papers). The work is most often cited by research in Hepatology (92 citations), Internal Medicine (18 citations) and Cancer Research (65 citations). Hongying Su has collaborated with scholars based in China and United States. Frequent co-authors include Han Bao, Xiongfei Huang, Aimin Huang, Wendong Huang, Jingfeng Liu, Xichun Wang, Ningbo Li, Jingsong Mao, Dan Long and Changhui Fu. Their work appears in journals such as Biomaterials, Biochemical and Biophysical Research Communications and Nanoscale.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.